These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 9596701
1. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Jin F, Nathan CF, Radzioch D, Ding A. Infect Immun; 1998 Jun; 66(6):2447-52. PubMed ID: 9596701 [Abstract] [Full Text] [Related]
2. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection]. Sano C, Shimizu T, Sato K, Ogasawara K, Tomioka H. Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411 [Abstract] [Full Text] [Related]
3. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Yang J, Zhu J, Sun D, Ding A. Biochim Biophys Acta; 2005 Sep 30; 1745(3):310-7. PubMed ID: 16112212 [Abstract] [Full Text] [Related]
4. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages. Sano C, Shimizu T, Tomioka H. Cytokine; 2003 Jan 07; 21(1):38-42. PubMed ID: 12668158 [Abstract] [Full Text] [Related]
5. Identification of genes involved in innate responsiveness to bacterial products by differential display. Jin F, Nathan C, Ding A. Methods; 1998 Dec 07; 16(4):396-406. PubMed ID: 10049647 [Abstract] [Full Text] [Related]
6. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Jin FY, Nathan C, Radzioch D, Ding A. Cell; 1997 Feb 07; 88(3):417-26. PubMed ID: 9039268 [Abstract] [Full Text] [Related]
7. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM. J Immunol; 2004 Apr 01; 172(7):4535-44. PubMed ID: 15034071 [Abstract] [Full Text] [Related]
8. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. Odaka C, Mizuochi T, Yang J, Ding A. J Immunol; 2003 Aug 01; 171(3):1507-14. PubMed ID: 12874244 [Abstract] [Full Text] [Related]
9. Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages. Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H. Clin Exp Immunol; 2000 Jul 01; 121(1):77-85. PubMed ID: 10886242 [Abstract] [Full Text] [Related]
10. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, Takai T, Nukiwa T. J Exp Med; 2003 Mar 03; 197(5):669-74. PubMed ID: 12615907 [Abstract] [Full Text] [Related]
11. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection. Choi BD, Jeong SJ, Wang G, Kim HJ, Kim BO, Hwang HK, Lim DS, Kim SH, Jeong MJ. J Endod; 2009 Jul 03; 35(7):997-1002. PubMed ID: 19567322 [Abstract] [Full Text] [Related]
12. Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S. Infect Immun; 1999 Sep 03; 67(9):4485-9. PubMed ID: 10456890 [Abstract] [Full Text] [Related]
13. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Grobmyer SR, Barie PS, Nathan CF, Fuortes M, Lin E, Lowry SF, Wright CD, Weyant MJ, Hydo L, Reeves F, Shiloh MU, Ding A. Crit Care Med; 2000 May 03; 28(5):1276-82. PubMed ID: 10834665 [Abstract] [Full Text] [Related]
14. 660 nm Red LED Induces Secretory Leukocyte Protease Inhibitor (SLPI) in Lipopolysaccharide-Stimulated RAW264.7 Cell. Jeong SJ, Choi BD, Lee HY, Hwang YH, Kim BH, Cho YI, Yun JJ, Lee BH, Jeong MJ. J Nanosci Nanotechnol; 2015 Aug 03; 15(8):5610-6. PubMed ID: 26369126 [Abstract] [Full Text] [Related]
15. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O'Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M. Hepatology; 2014 Apr 03; 59(4):1564-76. PubMed ID: 24282114 [Abstract] [Full Text] [Related]
16. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor. Zhu J, Nathan C, Ding A. Biochim Biophys Acta; 1999 Sep 21; 1451(2-3):219-23. PubMed ID: 10556576 [Abstract] [Full Text] [Related]
17. Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination. Taggart CC, Greene CM, McElvaney NG, O'Neill S. J Biol Chem; 2002 Sep 13; 277(37):33648-53. PubMed ID: 12084717 [Abstract] [Full Text] [Related]
18. Induction of macrophage-derived SLPI by Mycobacterium tuberculosis depends on TLR2 but not MyD88. Ding A, Yu H, Yang J, Shi S, Ehrt S. Immunology; 2005 Nov 13; 116(3):381-9. PubMed ID: 16236128 [Abstract] [Full Text] [Related]
19. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. King AE, Fleming DC, Critchley HO, Kelly RW. Mol Hum Reprod; 2002 Apr 13; 8(4):341-9. PubMed ID: 11912282 [Abstract] [Full Text] [Related]
20. [Secretory leukocyte peptidase inhibitor inhibits the inflammatory response and apoptosis of lipopolysaccharide-induced human proximal renal tubular cells]. Zhang D, Wang W, Shao R, Wang Y, Wu Z, Lu H. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul 13; 34(7):724-726. PubMed ID: 36100410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]